Charles River Laboratories International, Inc. (CRL)
Charles River Laboratories International, Inc. is listed on NYSE (CRL) in the Healthcare sector. Prices from Yahoo Finance with their delay; analysis computed from daily price history.
All stocks — US stocks · Heatmap
- Exchange
- NYSE · Closed Opens in 22h 01m
- Data delay
- 20 min
- Day range
- 316.61 – 339.94
- Prev. close
- 313.02
Key statistics
- Open
- 318.73
- Previous close
- 313.02
- 52-week range
- 146.20 – 379.63
- Volume
- 1.1M
- Avg volume (3M)
- 1.1M
- Market cap
- 16.2B USD
- P/E (TTM)
- 366.9
- EPS (TTM)
- 0.92
- Dividend yield
- 0.00%
- Sector
- Healthcare Diagnostics & Research
- Listed in
- S&P 500
- Currency
- USD
Chart
Movement expectation (statistical)
Ranges the price would stay in with a given probability if its recent volatility continues.
| Horizon | ≈68% range (±1σ) | ≈95% range (±2σ) | Past fit |
|---|---|---|---|
| Next trading day | 327.46 – 347.89 ±3.07% | 317.70 – 358.57 | 78% / 94% of the last 250 periods stayed inside |
| Next 5 trading days | 315.44 – 361.14 ±7.00% | 294.81 – 386.42 | 71% / 91% of the last 251 periods stayed inside |
ATR range (Next trading day): 320.03 – 355.01 · (Next 5 trading days): 298.41 – 376.63
Daily volatility (σ, 60 days): 3.03%. Basis: close of 2026-11-06 and current price.
⚠️ These are statistical ranges calculated from the stock's own past volatility. They are not a price target, a forecast or a recommendation to buy or sell. Prices can and do move outside them, especially around earnings and news.
Trend reading
Uptrend A description of the indicators, not a recommendation.
- Price is above its 200-day average: the long-term trend is up.
- The 50-day average is above the 200-day (golden-cross structure).
- Short term: above both the 20- and 50-day averages.
- RSI 53.7: neutral zone (30–70).
- MACD is below its signal line (negative momentum).
- 11.1% below the 52-week high.
Pivot points
| Classic | Fibonacci | |
|---|---|---|
| R3 | 369.48 | 354.73 |
| R2 | 354.73 | 345.80 |
| R1 | 346.12 | 340.29 |
| P | 331.37 | 331.37 |
| S1 | 322.76 | 322.44 |
| S2 | 308.01 | 316.93 |
| S3 | 299.40 | 308.01 |
From the 2026-11-06 daily bar (H 339.97 · L 316.61 · C 337.52)
Moving averages
| Moving averages | Price | MA signal |
|---|---|---|
| SMA20 | 334.16 | Above |
| SMA50 | 306.52 | Above |
| SMA200 | 225.15 | Above |
| EMA20 | 332.70 | Above |
| EMA50 | 310.50 | Above |
MA signal: Strong buy · RSI (14): 53.7 · 1M volatility (ann.): 65.7%
Performance
MACD (12, 26, 9)
- MACD
- 9.710
- Signal
- 13.312
- Histogram
- -3.601
- ATR (14)
- 17.49
Position in the sector heatmap
Today #1 of 61 Healthcare stocks in US by change; sector average -0.05%.
Sector peers
Largest Healthcare stocks in US by market cap
| Eli Lilly and CompanyLLY | 1,354.00 USD | -0.79% | 3.6M | 1.21T USD | Healthcare |
|---|---|---|---|---|---|
| Johnson & JohnsonJNJ | 276.22 USD | +1.43% | 8.9M | 664.9B USD | Healthcare |
| AbbVie Inc.ABBV | 291.31 USD | +1.07% | 5M | 514.9B USD | Healthcare |
| Merck & Co., Inc.MRK | 146.73 USD | -0.14% | 7.5M | 361.7B USD | Healthcare |
| UnitedHealth Group IncorporatedUNH | 394.15 USD | -0.40% | 5.8M | 353.2B USD | Healthcare |
| Thermo Fisher Scientific Inc.TMO | 694.76 USD | +2.63% | 2.1M | 257.4B USD | Healthcare |
| Amgen Inc.AMGN | 460.42 USD | +0.03% | 2.6M | 249B USD | Healthcare |
| Gilead Sciences, Inc.GILD | 166.89 USD | -0.41% | 5.7M | 207B USD | Healthcare |
| Abbott LaboratoriesABT | 109.93 USD | -3.23% | 8.2M | 190.4B USD | Healthcare |
| Pfizer Inc.PFE | 29.39 USD | -0.20% | 48.2M | 167.5B USD | Healthcare |
| Danaher CorporationDHR | 230.25 USD | +1.73% | 3.7M | 162B USD | Healthcare |
| Intuitive Surgical, Inc.ISRG | 452.80 USD | -3.36% | 2.1M | 157B USD | Healthcare |
| Charles River Laboratories International, Inc.CRL | 337.52 USD | +7.83% | 1.1M | 16.2B USD | Healthcare |
Delays: NYSE 20 min · Nasdaq 15 min